Your browser doesn't support javascript.
loading
Rituximab for acute demyelinating myelopathy after allogeneic hematopoietic stem cell transplantation: a case report.
Xing, Lina; Wen, Shupeng; Niu, Zhiyun; Wang, Fuxu; Zhang, Xuejun.
Affiliation
  • Xing L; Department of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical University , Shijiazhuang, China.
  • Wen S; Department of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical University , Shijiazhuang, China.
  • Niu Z; Department of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical University , Shijiazhuang, China.
  • Wang F; Department of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical University , Shijiazhuang, China.
  • Zhang X; Department of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical University , Shijiazhuang, China.
Postgrad Med ; 132(5): 485-488, 2020 Jun.
Article in En | MEDLINE | ID: mdl-32148146
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Demyelinating Diseases / Hematopoietic Stem Cell Transplantation / Rituximab / Immunologic Factors Limits: Adult / Humans / Male Language: En Journal: Postgrad Med Year: 2020 Document type: Article Affiliation country: China Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Demyelinating Diseases / Hematopoietic Stem Cell Transplantation / Rituximab / Immunologic Factors Limits: Adult / Humans / Male Language: En Journal: Postgrad Med Year: 2020 Document type: Article Affiliation country: China Country of publication: United kingdom